ArticleCureus2026
Predictors of Surgical Outcome After Anterior Cervical Discectomy and Fusion: A Prospective Middle Eastern Cohort Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Cervical disc prolapse is a common cause of radiculopathy and myelopathy. Anterior cervical discectomy and fusion (ACDF) is the standard surgical treatment, but prognostic factors such as age and the duration of symptoms remain debated. This study evaluated outcomes of ACDF and analyzed predictors of recovery. Methods Sixty-two patients with cervical disc prolapse underwent ACDF at a single tertiary neurosurgical center. Demographic data, clinical features, operative levels, outcomes, and complications were documented. Outcomes were categorized as improved, unchanged, or deteriorated at final follow-up. Patients were stratified by age (30-39, 40-49, 50-59, and ≥60 years), gender, and symptom duration (<6 months, 6-24 months, and >24 months). Chi-square (χ²) tests were used for associations, with significance at p < 0.05. Results The mean age was 49.3 years (range: 31-67); there were 22 men and 40 women. The most common level affected was C5-C6 in 36 (57.1%) patients. Presenting symptoms included upper limb sensory complaints in 54 (87.1%) patients and neck pain in 50 (80.6%) patients. At final follow-up, 52 (83.9%) patients improved, eight (12.9%) remained unchanged, and two (3.2%) deteriorated. The duration of symptoms significantly affected outcomes: all patients treated within six months (22) improved, compared with 26 out of 32 (81.3%) in those with 6-24 months and four out of eight (50%) with >24 months (χ² = 11.18; p = 0.0037). Age was also significant, with four out of eight patients aged ≥60 years showing lower improvement (50%) compared with 24 out of 26 (92.3%) in the 50-59 age group (χ² = 8.31; p = 0.040). Gender did not influence outcome (18 of 22 men {81.8%} versus 34 of 40 women {85%}, p = 0.61). Complications occurred in six of 62 patients (9.7%), including transient dysphagia in four (6.5%) and transient hoarseness in two (3.2%), with no mortality. Conclusion ACDF is an effective and safe treatment for cervical disc prolapse, achieving high neurological recovery with a low complication rate. Outcomes are significantly influenced by symptom duration and patient age but not by gender. Early surgical intervention provides the most favorable prognosis, supporting prompt referral and management in suitable candidates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.